These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12578850)

  • 41. Effect of an exogenous trigger on the pathogenesis of lupus in (NZB x NZW)F1 mice.
    Yoshida H; Satoh M; Behney KM; Lee CG; Richards HB; Shaheen VM; Yang JQ; Singh RR; Reeves WH
    Arthritis Rheum; 2002 Aug; 46(8):2235-44. PubMed ID: 12209530
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis.
    Liao W; Zheng H; Wu S; Zhang Y; Wang W; Zhang Z; Zhou C; Wu H; Min J
    Am J Nephrol; 2017; 46(5):371-379. PubMed ID: 29069649
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immune tolerance to autoantibody-derived peptides delays development of autoimmunity in murine lupus.
    Singh RR; Ebling FM; Sercarz EE; Hahn BH
    J Clin Invest; 1995 Dec; 96(6):2990-6. PubMed ID: 8675671
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An Ig mu-heavy chain transgene inhibits systemic lupus erythematosus immunopathology in autoimmune (NZB x NZW)F1 mice.
    Wellmann U; Letz M; Schneider A; Amann K; Winkler TH
    Int Immunol; 2001 Dec; 13(12):1461-9. PubMed ID: 11717187
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Natural antibodies that react with V-region peptide epitopes of DNA-binding antibodies are made by mice with systemic lupus erythematosus as disease develops.
    Ward FJ; Knies JE; Cunningham C; Harris WJ; Staines NA
    Immunology; 1997 Nov; 92(3):354-61. PubMed ID: 9486108
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Ox40/Ox40 Ligand Pathway Promotes Pathogenic Th Cell Responses, Plasmablast Accumulation, and Lupus Nephritis in NZB/W F1 Mice.
    Sitrin J; Suto E; Wuster A; Eastham-Anderson J; Kim JM; Austin CD; Lee WP; Behrens TW
    J Immunol; 2017 Aug; 199(4):1238-1249. PubMed ID: 28696253
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mercury-induced renal immune complex deposits in young (NZB x NZW)F1 mice: characterization of antibodies/autoantibodies.
    Abedi-Valugerdi M; Hu H; Möller G
    Clin Exp Immunol; 1997 Oct; 110(1):86-91. PubMed ID: 9353153
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of bisphenol A on murine immune function: modulation of interferon-gamma, IgG2a, and disease symptoms in NZB X NZW F1 mice.
    Sawai C; Anderson K; Walser-Kuntz D
    Environ Health Perspect; 2003 Dec; 111(16):1883-7. PubMed ID: 14644661
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Murine models of systemic lupus erythematosus: B and T cell responses to spliceosomal ribonucleoproteins in MRL/Fas(lpr) and (NZB x NZW)F(1) lupus mice.
    Monneaux F; Dumortier H; Steiner G; Briand JP; Muller S
    Int Immunol; 2001 Sep; 13(9):1155-63. PubMed ID: 11526096
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DNAse treatment does not improve the survival of lupus prone (NZB x NZW)F1 mice.
    Verthelyi D; Dybdal N; Elias KA; Klinman DM
    Lupus; 1998; 7(4):223-30. PubMed ID: 9643311
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glatiramer acetate treatment does not modify the clinical course of (NZB x BXSB)F1 lupus murine model.
    Borel P; Benkhoucha M; Weber MS; Zamvil SS; Santiago-Raber ML; Lalive PH
    Int Immunol; 2008 Oct; 20(10):1313-9. PubMed ID: 18687587
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Control of separate pathogenic autoantibody responses marks MHC gene contributions to murine lupus.
    Vyse TJ; Halterman RK; Rozzo SJ; Izui S; Kotzin BL
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):8098-103. PubMed ID: 10393954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High frequency of autoantibody-secreting cells and long-lived plasma cells within inflamed kidneys of NZB/W F1 lupus mice.
    Starke C; Frey S; Wellmann U; Urbonaviciute V; Herrmann M; Amann K; Schett G; Winkler T; Voll RE
    Eur J Immunol; 2011 Jul; 41(7):2107-12. PubMed ID: 21484784
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Suppression of renal disease and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE) by chenodeoxycholic acid.
    Suwannaroj S; Lagoo A; McMurray RW
    Lupus; 2001; 10(8):562-7. PubMed ID: 11530998
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SM934 treated lupus-prone NZB × NZW F1 mice by enhancing macrophage interleukin-10 production and suppressing pathogenic T cell development.
    Hou LF; He SJ; Li X; Wan CP; Yang Y; Zhang XH; He PL; Zhou Y; Zhu FH; Yang YF; Li Y; Tang W; Zuo JP
    PLoS One; 2012; 7(2):e32424. PubMed ID: 22389703
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IL-4Ralpha polymorphism in regulation of IL-4 synthesis by T cells: implication in susceptibility to a subset of murine lupus.
    Shiroiwa W; Tsukamoto K; Ohtsuji M; Lin Q; Ida A; Kodera S; Ohtsuji N; Nakamura K; Tsurui H; Kinoshita K; Nishimura H; Shirai T; Hirose S
    Int Immunol; 2007 Feb; 19(2):175-83. PubMed ID: 17189592
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cyclin-dependent kinase inhibition limits glomerulonephritis and extends lifespan of mice with systemic lupus.
    Zoja C; Casiraghi F; Conti S; Corna D; Rottoli D; Cavinato RA; Remuzzi G; Benigni A
    Arthritis Rheum; 2007 May; 56(5):1629-37. PubMed ID: 17469145
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antioxidants suppress mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE).
    Suwannaroj S; Lagoo A; Keisler D; McMurray RW
    Lupus; 2001; 10(4):258-65. PubMed ID: 11341102
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A peptide based on the sequence of the CDR3 of a murine anti-DNA mAb is a better modulator of experimental SLE than its single amino acid-substituted analogs.
    Brosh N; Zinger H; Fridkin M; Mozes E
    Cell Immunol; 2000 Oct; 205(1):52-61. PubMed ID: 11078607
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB x NZW)F1 mice.
    Reininger L; Winkler TH; Kalberer CP; Jourdan M; Melchers F; Rolink AG
    J Exp Med; 1996 Sep; 184(3):853-61. PubMed ID: 9064345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.